Product Name:N1-(2-(Dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)-2-nitrobenzene-1,4-diamine

IUPAC Name:N1-[2-(dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]-2-nitrobenzene-1,4-diamine

CAS:1421372-67-9
Molecular Formula:C25H29N7O3
Purity:95%
Catalog Number:CM147322
Molecular Weight:475.55

Packing Unit Available Stock Price($) Quantity
CM147322-5g in stock ŽřǸ
CM147322-10g in stock ŽƚǸ
CM147322-25g in stock ǟƚij

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:1421372-67-9
Molecular Formula:C25H29N7O3
Melting Point:-
Smiles Code:O=[N+](C1=CC(NC2=NC=CC(C3=CN(C)C4=C3C=CC=C4)=N2)=C(OC)C=C1N(CCN(C)C)C)[O-]
Density:
Catalog Number:CM147322
Molecular Weight:475.55
Boiling Point:695.0±65.0°C at 760 mmHg
MDL No:MFCD28167947
Storage:Keep in dark place, store at 2-8°C.

Column Infos

Indoles
Indole is a compound of pyrrole and benzene in parallel, also known as benzopyrrole. There are two combinations of pyrrole and benzene, called indole and isoindole, respectively. Many derivatives of indole have physiological and pharmacological activities, and can synthesize vasodilators, antihistamines, antipyretic analgesics, etc. in medicine, so indole is also a very important heterocyclic compound.
Osimertinib
TAGRISSO (osimertinib) demonstrated overwhelming efficacy benefit for patients with unresectable, Stage III EGFR-mutated lung cancer in LAURA Phase III trial.
TAGRISSO (osimertinib) is a third-generation, irreversible EGFR-TKI with proven clinical activity in NSCLC, including against central nervous system metastases. It is the first and only EGFR TKI recommended by NCCN Guidelines as an adjuvant treatment option for completely resected stage IB-IIIA, stage IIIB (T3, N2) EGFRm (exon 19 deletion, exon 21 L858R mutation) NSCLC.